the Effect of Aerobic Training on Insulin Sensitivity on Diabetic Patients During Tobacco Cessation

NCT ID: NCT05624970

Last Updated: 2022-11-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-11-09

Study Completion Date

2023-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

* Prevalence of smoking in men and women ages 15 and over who currently smoke any tobacco product on a daily or non-daily basis Egypt smoking rate for 2018 was 21.40%, a 0.1% increase from 2016.
* According to WHO reports, smoking is currently responsible for six million premature deaths every year, of which 600 000 individuals die from the effects of second-hand smoke.
* Egypt is one of the 21 countries and territories of the International Diabetes Federation Middle East and North Africa (MENA) region. 463 million people have diabetes in the world and 55 million people in the MENA Region; by 2045 this will rise to 108 million.
* The most profound impact of smoking in diabetic patients is on insulin sensitivity, Cigarette smoking worsens insulin-resistance in patients with diabetes, as smoking decreases subcutaneous absorption of insulin, resulting in increased dosing requirements. When the action of insulin is impaired chronically in smokers, a dose response relationship can be seen between the number of cigarettes smoked and the degree of insulin resistance. Consequently, quitting smoking should improve glycemic control.
* Therefore diabetic patients can get huge benefits from tobacco cessation as they give their bodies chance to decrease percentage of nicotine and increase percentage of insulin so decrease risk of getting atherosclerosis, so smoking cessation improve glycemic control and insulin sensitivity.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Diabetes is a complex, chronic illness requiring continuous medical care with multifactorial risk-reduction strategies beyond glycemic control. Ongoing diabetes self-management education and support are critical to preventing acute complications and reducing the risk of long-term complications.

Nowadays, the harmful effect of smoking is no secret to anyone, unfortunately it is still causes the loss of lives for many adults and young peoples. The Ministry of Health (MOH) seeks to control it and help smokers to quit to save their lives and protect them against smoking-caused diseases such as smoking slows down lung growth in children and teens, increases a person's risk of getting tuberculosis, increases the risk of developing type2 diabetes, also most of COPD (Chronic Obstructive Pulmonary Disease) deaths are a result of smoking. The term "smoking" is not restricted to cigarette smoking only, but includes e-cigarette, shisha and others.

Although cigarette smoking is the leading avoidable cause of death, its specific effects on people with diabetes are even more intricate and profound, thus the macrovascular and microvascular complications become more quickly in smokers with diabetes, and risk of mortality increases. The increased blood pressure and altered lipid profiles in smokers with diabetes could encourage development of the insulin resistance syndrome, setting patients up for further cardiovascular problems.

One of the biggest problems for most patients undergoing a cessation program is the fear of withdrawal symptoms, including cravings, anxiety, depression, irritability, sleep disturbances, increased hunger and weight gain.

Aerobic exercise program for type 2 diabetic has showed great effects not only on glycemic control, blood lipid profiles profile, but also on reducing metabolic risk factors for cardiovascular diseases including insulin resistance. Previous studies have showed the effects of moderate-intensity exercise on the improvement of insulin sensitivity.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diabetes

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Sixty smokers male their age ranged from 40-50 years old will be selected from diabetic outpatient clinic Qasr AL-Einy Hospital. All patients will be carefully examined by the physicians of the hospital. They will be randomly assigned into two groups equal in numbers, as group (A) and group (B).

Group (A):

This group will consist of 30 patients who will receive the medical treatment (oral hypoglycemic drugs), aerobic training, tobacco cessation program and nutritional advices for 12 weeks.

Group (B):

This group will consist of 30 patients who will receive the medical treatment (oral hypoglycemic drugs), tobacco cessation program and nutritional advices for 12 weeks.
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

group (A)

Group (A):

This group will consist of 30 patients who will receive the medical treatment (oral hypoglycemic drugs), aerobic training, tobacco cessation program and nutritional advices for 12 weeks.

Group Type EXPERIMENTAL

aerobic training , tobacco cessation and nutritional advices

Intervention Type BEHAVIORAL

1. Aerobic training program according to Taheri et al 2017:

* Mode: recruits large groups of muscles and includes brisk walking on treadmill, cycling, swimming, and jogging
* Intensity: submaximal aerobic exercise program (50-60% of maximal heart rate reserve) on treadmill
* Frequency: 3 sessions a week for 2 months.
* Duration: 60 min/session The training protocol was divided into three phases: the warm up period (10 minutes), the main program (aerobic exercise; 40 minutes), and a cool down period (10 minutes).
2. Tobacco Cessation Programs for 3 months
3. Nutritional advices according to American Diabetes Association (ADA) 2015: for 3 months

group (B)

Group (B):

This group will consist of 30 patients who will receive the medical treatment (oral hypoglycemic drugs), tobacco cessation program and nutritional advices for 12 weeks.

Group Type EXPERIMENTAL

tobacco cessation and nutritional advices

Intervention Type BEHAVIORAL

Tobacco Cessation Programs for 3 months Nutritional advices according to American Diabetes Association (ADA) 2015: for 3 months

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

aerobic training , tobacco cessation and nutritional advices

1. Aerobic training program according to Taheri et al 2017:

* Mode: recruits large groups of muscles and includes brisk walking on treadmill, cycling, swimming, and jogging
* Intensity: submaximal aerobic exercise program (50-60% of maximal heart rate reserve) on treadmill
* Frequency: 3 sessions a week for 2 months.
* Duration: 60 min/session The training protocol was divided into three phases: the warm up period (10 minutes), the main program (aerobic exercise; 40 minutes), and a cool down period (10 minutes).
2. Tobacco Cessation Programs for 3 months
3. Nutritional advices according to American Diabetes Association (ADA) 2015: for 3 months

Intervention Type BEHAVIORAL

tobacco cessation and nutritional advices

Tobacco Cessation Programs for 3 months Nutritional advices according to American Diabetes Association (ADA) 2015: for 3 months

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

According to the following:

* All patients will be male.
* Their age between 40-50 years old
* Their BMI 18.5-29.9 kg/m2
* They are diagnosed as type II diabetes for more than 5 years
* Their HbA1c value from \> 6.5%
* Smokers for more than10-15 years
* Their smoking index will be moderate and heavy
* All patients are under full medical supervision
* All patients will quit smoking 1-7 days before undergoes aerobic training program

Exclusion Criteria

All patients will not have:

* Any patient is known to have any unstable medical condition.
* Any musculoskeletal or neurological disorder
* Hepatic diseases.
* Kidney disorders
* Type I diabetes mellitus
* Type II insulin
* Uncontrolled hypertension
* Unstable angina pectoris
* Uncompensated heart failure
* Recent myocardial infarction
* Heart block
* Cerebrovascular disease
* Anemia
* Patients whose smoking index light
* Tobacco smokers less than 20 years
Minimum Eligible Age

40 Years

Maximum Eligible Age

50 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Cairo University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Alaa Mohamed Naguib Ashry

assistant lecturer at faculty of physical therapy

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Nesreen Elnahas, professor

Role: STUDY_DIRECTOR

Cairo Univeristy

Rana elbanaa, lecturer

Role: STUDY_DIRECTOR

Cairo Univeristy

Yasmine mohamed, lectuere

Role: STUDY_DIRECTOR

cairo univeristy

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Alaa mohamed Naguib

Cairo, , Egypt

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Alaa Naguib, Ass. lect.

Role: CONTACT

01092224967

Nesreen Elnahas, professor

Role: CONTACT

01002227242

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

P.T.REC/012/003343

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.